$1.83+0.00 (+0.27%)
News21/Ratings0
Price$1.83+0.11 (+6.69%)
01:30 PM07:45 PM
News · 26 weeks15-50%
2025-11-022026-04-26
Mix590d
- SEC Filings3(60%)
- Other2(40%)
Latest news
21 items- SECSEC Form 6-K filed by Ridgetech Inc.6-K - Ridgetech Inc. (0001856084) (Filer)
- SECSEC Form 6-K filed by Ridgetech Inc.6-K - Ridgetech Inc. (0001856084) (Filer)
- PRRidgetech, Inc. Announces 1-for-150 Reverse Share SplitHANGZHOU, China, April 3, 2026 /PRNewswire/ -- Ridgetech, Inc., a Cayman Islands exempted company (the "Company") (NASDAQ:RDGT), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that it expects to implement a 1-for-150 reverse share split on its ordinary shares ("Ordinary Shares") effective Tuesday, April 7, 2026 at 5:00 p.m. Eastern Time, with trading to begin on a split‑adjusted basis at the market open on the next trading day. Trading in the Ordinary Shares will continue on the Nasdaq Capital Market under the symbol "RDGT." The new CUSIP number for the Ordinary Shares following the reverse share split is G2124G 203. As of April 2, 2026, the
- SECSEC Form 6-K filed by Ridgetech Inc.6-K - Ridgetech Inc. (0001856084) (Filer)
- PRRidgetech Unveils 2026 Dual-Engine Growth Strategy to Drive Innovation and Value CreationHANGZHOU, China, March 4, 2026 /PRNewswire/ -- Ridgetech, Inc. (NASDAQ:RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced its dual-engine growth strategy for 2026. The strategy centers on supply chain integration by leveraging its wholesale distribution network, B2B platform, and franchise system. Building on its integrated pharmaceutical and healthcare service platforms, Ridgetech aims to achieve parallel breakthroughs in both business model innovation and value creation, thereby strengthening its long-term growth foundation across China's pharmaceutical and healthcare supply chain. Further Strengthening Co
- SECSEC Form 424B5 filed by Ridgetech Inc.424B5 - Ridgetech Inc. (0001856084) (Filer)
- SECSEC Form 6-K filed by Ridgetech Inc.6-K - Ridgetech Inc. (0001856084) (Filer)
- SECSEC Form 6-K filed by Ridgetech Inc.6-K - Ridgetech Inc. (0001856084) (Filer)
- SECSEC Form EFFECT filed by Ridgetech Inc.EFFECT - Ridgetech Inc. (0001856084) (Filer)
- SECSEC Form 6-K filed by Ridgetech Inc.6-K - Ridgetech Inc. (0001856084) (Filer)
- SECSEC Form F-3 filed by Ridgetech Inc.F-3 - Ridgetech Inc. (0001856084) (Filer)
- SECSEC Form 6-K filed by Ridgetech Inc.6-K - Ridgetech Inc. (0001856084) (Filer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Ridgetech Inc.SCHEDULE 13D/A - Ridgetech Inc. (0001856084) (Subject)
- SECSEC Form 6-K filed by Ridgetech Inc.6-K - Ridgetech Inc. (0001856084) (Filer)
- SECSEC Form 6-K filed by Ridgetech Inc.6-K - Ridgetech Inc. (0001856084) (Filer)
- SECSEC Form RW filed by Ridgetech Inc.RW - Ridgetech Inc. (0001856084) (Filer)
- SECSEC Form F-1 filed by Ridgetech Inc.F-1 - Ridgetech Inc. (0001856084) (Filer)
- SECSEC Form 20-F filed by Ridgetech Inc.20-F - Ridgetech Inc. (0001856084) (Filer)
- SECSEC Form 6-K filed by Ridgetech Inc.6-K - Ridgetech Inc. (0001856084) (Filer)
- PRRidgetech, Inc. Reports Fiscal Year 2025 Financial ResultsHANGZHOU, China, July 28, 2025 /PRNewswire/ -- Ridgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced its financial results for the fiscal year ended March 31, 2025. Mr. Frank Zhao, Interim Chief Executive Officer and Chief Financial Officer of Ridgetech, commented, "We are pleased to present a relatively stable revenue outcome for fiscal year 2025, a year marked by significant transformation for the Company. During this period, we divested our retail pharmacy business and acquired Ridgeline and its subsidiary, Allright (Hangzhou) Internet Technology Co. Ltd ("Allright"), marking our st
- SECSEC Form 6-K filed by Ridgetech Inc.6-K - Ridgetech Inc. (0001856084) (Filer)